C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) A61K 51/10 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01) C07K 16/46 (2006.01) C12N 5/10 (2006.01) C12P 21/08 (2006.01) G01N 33/574 (2006.01) G01N 33/92 (2006.01)
Patent
CA 2226400
A human CDR-grafted antibody which specifically reacts with ganglioside CM2, wherein said antibody comprises CDR 1, CDR 2 and CDR 3 of heavy chain (H chain) variable region (V region) comprising amino acid sequences described in SEQ ID NO:1, SEQ ID NO:2 and SEQ ID NO:3, and CDR 1, CDR 2 and CDR 3 of light chain (L chain) V region comprising amino acid sequences described in SEQ ID NO:4, SEQ ID NO: 5 and SEQ ID NO:6, and wherein at least one of the frameworks (FR) of said H chain and L chain V regions comprises an amino acid sequence selected from common sequences (HMECS; human most homologous consensus sequence) derived from human antibody subgroups.
Hanai Nobuo
Nakamura Kazuyasu
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Kyowa Hakko Kirin Co. Ltd.
Kyowa Hakko Kogyo Co. Ltd.
LandOfFree
Human complementarity determining region (cdr) - grafted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human complementarity determining region (cdr) - grafted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human complementarity determining region (cdr) - grafted... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1663324